Skip to main content

Table 2 Change in the RDQ scales from baseline to 2 weeks, by patient rating of the Overall Treatment Evaluation (OTE)

From: The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials

OTE

N

Heartburn

Regurgitation

Dyspepsia

GERDa

  

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Esomeprazole

Worse

6

0.04

2.00

-0.42

0.41

-0.08

1.47

-0.19

1.20

The same

36

0.76

1.48

0.68

1.11

0.31

1.24

0.71

0.99

A little better

43

1.60

1.46

1.52

1.08

1.27

1.64

1.56

0.97

Much better

231

2.74

1.26

2.25

1.42

1.94

1.59

2.51

1.08

All

316

2.31

1.52

1.92

1.47

1.64

1.66

2.12

1.26

Placebo

Worse

3

0.42

1.18

-0.25

0.25

0.50

0.43

0.08

0.63

The same

26

0.42

1.54

0.37

1.30

0.27

1.41

0.37

1.08

A little better

28

0.88

1.0

1.05

1.10

0.78

1.20

0.90

0.72

Much better

22

2.10

1.26

1.38

1.82

1.65

1.68

1.74

1.33

All

79

1.05

1.43

0.86

1.43

0.86

1.50

0.93

1.17

  1. aHeartburn and regurgitation subscales combined. SD, standard deviation.